Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New EIAs in Microtiter Format for Cancer

By HospiMedica staff writers
Posted on 22 Jan 2002
A new line of six enzyme immunoassays (EIAs) in microtiter format has been announced by Fujirebio Diagnostics, Inc. More...
(FDI, Malvern, PA, USA), formerly known as Centocor Diagnostics.

The new EIAs will target ovarian cancer (CA 125II), breast cancer (CA15-3), pancreatic cancer (CA19-9), gastric cancer (CA72-4), and prostate cancer (total PSA and free PSA). The markers will be available in 96-well microtiter format, utilizing coated microwell strips, to provide laboratories with manual or automated options. The EIAs will be based on the same antibodies utilized in the company's diagnostic radioimmunoassays (RIAs). They will be available in Southeast Asia in this quarter and later launched in Latin America, the Middle East, and Eastern Europe. The assays were co-developed with Trinity Biotech (Dublin, Ireland).

"In many parts of the world, RIAs for these life-threatening cancers are not available because their radioactive elements cannot be shipped or because local laboratories cannot run them,” noted Aris Petropoulos, president and CEO of FDI. "By offering the microtiter format, we are making early detection of recurrent cancer available to people around the world, even in remote localities.”




Related Links:
Fujirebio

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.